Neuroinflammation in Alzheimer disease

MT Heneka, WM van der Flier, F Jessen… - Nature Reviews …, 2024‏ - nature.com
Increasing evidence points to a pivotal role of immune processes in the pathogenesis of
Alzheimer disease, which is the most prevalent neurodegenerative and dementia-causing …

Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies

J Zhang, Y Zhang, J Wang, Y **a, J Zhang… - Signal transduction and …, 2024‏ - nature.com
Alzheimer's disease (AD) stands as the predominant form of dementia, presenting significant
and escalating global challenges. Its etiology is intricate and diverse, stemming from a …

The importance of complement-mediated immune signaling in Alzheimer's disease pathogenesis

AF Batista, KA Khan, MT Papavergi… - International Journal of …, 2024‏ - mdpi.com
As an essential component of our innate immune system, the complement system is
responsible for our defense against pathogens. The complement cascade has complex …

Organoid extracellular vesicle-based therapeutic strategies for bone therapy

H Liu, J Su - Biomaterials Translational, 2023‏ - pmc.ncbi.nlm.nih.gov
With the rapid development of population ageing, bone-related diseases seriously affecting
the life of the elderly. Over the past few years, organoids, cell clusters with specific functions …

Proteomics Profiling of Extracellular Vesicle for Identification of Potential Biomarkers in Alzheimer's Disease: A Comprehensive Review

JJ Pei, CP Palanisamy, S Jayaraman… - Ageing Research …, 2024‏ - Elsevier
The intricate origins and diverse symptoms of Alzheimer's disease (AD) pose significant
challenges for both diagnosis and treatment. Exosomes and microvesicles, which carry …

Organoids and organoid extracellular vesicles-based disease treatment strategies

G Zhou, R Li, S Sheng, J Huang, F Zhou, Y Wei… - Journal of …, 2024‏ - Springer
Organoids are “mini-organs” that self-organize and differentiate from stem cells under in vitro
3D culture conditions, mimicking the spatial structure and function of tissues in vivo …

The schizophrenia risk gene C4 induces pathological synaptic loss by impairing AMPAR trafficking

RA Phadke, A Brack, LA Fournier, E Kruzich… - Molecular …, 2024‏ - nature.com
Neuroimmune interactions play a significant role in regulating synaptic plasticity in both the
healthy and diseased brain. The complement pathway, an extracellular proteolytic cascade …

Challenges associated with using extracellular vesicles as biomarkers in neurodegenerative disease

Y Couch - Expert Review of Molecular Diagnostics, 2023‏ - Taylor & Francis
Introduction The hunt for new biomarkers–for the diagnosis of subcategories of disease, or
for the monitoring of the efficacy of novel therapeutics–is an increasingly relevant challenge …

Proteomic comparison between non‐purified cerebrospinal fluid and cerebrospinal fluid‐derived extracellular vesicles from patients with Alzheimer's, Parkinson's and …

Y Hirschberg, N Valle‐Tamayo… - Journal of …, 2023‏ - Wiley Online Library
Dementia is a leading cause of death worldwide, with increasing prevalence as global life
expectancy increases. The most common neurodegenerative disorders are Alzheimer's …

Complement 3a induces the synapse loss via C3aR in mitochondria-dependent NLRP3 activating mechanisms during the development and progression of …

TQ Ge, PP Guan, P Wang - Neuroscience & Biobehavioral Reviews, 2024‏ - Elsevier
As a central molecule in complement system (CS), complement (C) 3 is upregulated in the
animal models and patients of Alzheimer's disease (AD). C3 will metabolize to iC3b and …